MCRB
Seres Therapeutics Inc
NASDAQ: MCRB · HEALTHCARE · BIOTECHNOLOGY
$7.05
-0.56% today
Updated 2026-04-29
Market cap
$67.91M
P/E ratio
11.02
P/S ratio
86.07x
EPS (TTM)
$0.64
Dividend yield
—
52W range
$7 – $30
Volume
0.1M
Seres Therapeutics Inc (MCRB) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | $0.00 | $0.00 | $21.77M | $32.10M | $28.27M | $34.51M | $33.22M | $144.93M | $7.13M | $126.33M | $0.00 | $789000.00 |
| Revenue growth (YoY) | — | — | — | — | — | +47.5% | -11.9% | +22.1% | -3.7% | +336.3% | -95.1% | +1672.2% | -100.0% | — |
| Cost of revenue | — | — | $10.72M | $728000.00 | $81.99M | $89.45M | $95.95M | $80.14M | $90.57M | $141.89M | $1.00M | $704000.00 | $3.53M | $4.13M |
| Gross profit | — | — | $-10.72M | $-728000.00 | $-60.22M | $-57.35M | $28.27M | $34.51M | $-57.35M | $144.93M | $6.12M | $125.62M | $-3.53M | $-3.34M |
| Gross margin | — | — | — | — | -276.7% | -178.7% | 100.0% | 100.0% | -172.7% | 100.0% | 85.9% | 99.4% | — | -423.8% |
| R&D | $2.08M | $4.80M | $10.72M | $38.09M | $81.99M | $89.45M | $95.95M | $80.14M | $90.57M | $141.89M | $109.65M | $117.60M | $64.60M | $49.06M |
| SG&A | $956000.00 | $1.25M | $4.36M | $16.76M | $32.62M | $34.04M | $32.60M | $24.75M | $30.77M | $69.26M | $70.26M | $77.50M | $53.18M | $39.16M |
| Operating income | $-3.03M | $-6.05M | $-15.08M | $-54.86M | $-92.84M | $-91.39M | $-100.28M | $-71.88M | $-88.13M | $-64.49M | $-179.91M | $-195.10M | $-121.31M | $-93.97M |
| Operating margin | — | — | — | — | -426.5% | -284.7% | -354.8% | -208.3% | -265.3% | -44.5% | -2524.0% | -154.4% | — | -11910.1% |
| EBITDA | $-3.01M | $-5.96M | $-14.89M | $-54.13M | $-88.63M | $-82.12M | $-92.42M | $-62.17M | $-77.31M | $-56.72M | $-170.93M | $-181.42M | $-120.30M | $-89.84M |
| EBITDA margin | — | — | — | — | -407.2% | -255.8% | -327.0% | -180.2% | -232.8% | -39.1% | -2398.0% | -143.6% | — | -11386.3% |
| EBIT | $-3.03M | $-6.05M | $-15.08M | $-54.86M | $-92.84M | $-89.38M | $-100.28M | $-69.78M | $-86.20M | $-62.67M | $-177.56M | $-187.66M | $-125.77M | $-93.97M |
| Interest expense | $0.00 | $42000.00 | $0.00 | $555000.00 | $969000.00 | $1.59M | $1.17M | $502000.00 | $2.92M | $2.91M | $6.02M | $13.18M | $0.00 | $0.00 |
| Income tax | — | $42000.00 | $1.63M | $-804000.00 | $2.23M | $-1.59M | $1.34M | $-6.04M | $-2.67M | $-4.08M | $3.67M | $14.95M | $136000.00 | — |
| Effective tax rate | 0.0% | -0.7% | -10.8% | 1.4% | -2.5% | 1.7% | -1.4% | 7.9% | 2.9% | 5.9% | -1.5% | -15.1% | 50.0% | 0.0% |
| Net income | $-3.13M | $-6.10M | $-16.71M | $-54.78M | $-91.58M | $-89.38M | $-98.94M | $-70.28M | $-89.13M | $-65.58M | $-250.16M | $-113.72M | $136000.00 | $5.70M |
| Net income growth (YoY) | — | -95.2% | -173.8% | -227.8% | -67.2% | +2.4% | -10.7% | +29.0% | -26.8% | +26.4% | -281.5% | +54.5% | +100.1% | +4088.2% |
| Profit margin | — | — | — | — | -420.7% | -278.4% | -350.0% | -203.7% | -268.3% | -45.2% | -3509.5% | -90.0% | — | 721.9% |